The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

Background Angiotensin-converting enzyme 2 (ACE2) is known as the major viral entry site
for SARS-CoV-2. However, viral tissue tropism and high rate of infectivity do not directly …

Emergence of SARS‐CoV‐2 variants warrants sustainable efforts to upgrade both the
diagnostic and therapeutic protocols. Understanding the details of cellular and molecular …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown diverse life-
threatening effects, most of which are considered short-term. In addition to its short-term …

MERS-coronavirus is a novel zoonotic pathogen which spread rapidly to> 25 countries since
2012. Its apparent endemicity and the wide spread of its reservoir host (dromedary camels) …

We recently reported acute COVID-19 symptoms, clinical status, weight loss, multi-organ
pathological changes, and animal death in a murine hepatitis virus-1 (MHV-1) coronavirus …

The world has been suffering from the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic, and millions of people have been infected through human-to …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cytotoxicity may involve
inhibition of peroxisome proliferator-activated receptor alpha. Fenofibrate activates …

Introduction: The new coronavirus has caused a pandemic that has infected hundreds of
millions of people around the world since its outbreak. But the cardiovascular damage …

Background: During late 2019 a viral disease due to a novel coronavirus was reported in
Wuhan, China, which rapidly developed into an exploding pandemic and poses a severe …